SUIT-036 O2 mt D089: Difference between revisions
No edit summary |
No edit summary |
||
Line 23: | Line 23: | ||
:::: 2. to evaluate mitochondrial physiological diversity, generating a mt-database on comparative mitochondrial physiology. | :::: 2. to evaluate mitochondrial physiological diversity, generating a mt-database on comparative mitochondrial physiology. | ||
:::: 3. to screen specific defects. | :::: 3. to screen specific defects. | ||
:::* A succinate concentration of >10 mM may be required for saturating S<sub>''E''</sub> capacity. | :::* A succinate concentration of >10 mM may be required for saturating S<sub>''E''</sub> capacity. | ||
:::+ SUIT- | :::+ SUIT-036 allows the depletion of endogenous substrates with ADP (1D). | ||
:::+ The protocol provides information on F-pathway in OXPHOS state. The low concentration of malate used in this protocol, typically 0.1 mM, does not saturate the N-pathway; but saturates the F-pathway. ย | :::+ The protocol provides information on F-pathway in OXPHOS state. The low concentration of malate used in this protocol, typically 0.1 mM, does not saturate the N-pathway; but saturates the F-pathway. ย | ||
:::+ F-pathway (3Oct-2M.1) can be compared to FN-pathway (5P) in OXPHOS state. | :::+ F-pathway (3Oct-2M.1) can be compared to FN-pathway (5P) in OXPHOS state. | ||
Line 41: | Line 40: | ||
== Compare SUIT protocols == | == Compare SUIT protocols == | ||
::::* [[SUIT- | ::::* [[SUIT-037 O2 mt D090]]: ย | ||
::::* [[SUIT- | ::::* [[SUIT-038 O2 mt D091]] | ||
ย | |||
::::* [[SUIT-002 O2 mt D005]]: Harmonized SUIT protocol for isolated mitochondria, tissue homogenate and permeabilized cells (already permeabilized). | |||
== Chemicals and syringes == | == Chemicals and syringes == | ||
Line 51: | Line 52: | ||
== References == | == References == | ||
Revision as of 09:57, 12 April 2023
Description
Abbreviation: RP2 mt
Reference: A - SUIT-036 - ...
SUIT number: D089_1D;2M.1;3Pal;3c;4M.2;4M.5;4M1;4M2;5P;6G;7S10;7S50;8Gp;9U;10Rot;11Ama
O2k-Application: O2
The SUIT-036 O2 mt D089 protocol provides a common reference for comparison of respiratory control of mitochondrial preparations such as isolated mitochondria, tissue homogenates and permeabilized cells (already permeabilized when they are added to the chamber) in a wide variety of species, tissues and cell types. SUIT-036 O2 mt D089 is specially designed to give information on F-pathway with palmitoylcarnitine as a FAO substrate in OXPHOS state avoiding FAO overestimation in the presence of anaplerotic pathways. The careful titration of malate is required to analyze the activity of the mt-isoform of NADP- or NAD(P)-dependent malic enzyme (mtME). Moreover, the pathway control in OXPHOS state (F, F(N), FN, FNS, FNSGp pathways) and in ET state (FNSGp and SGp) can be evaluated by using this SUIT protocol.
Communicated by Doerrier C and Gnaiger E (last update 2019-09-24)
Representative traces
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
1D | ROX | 1D
| ||
2M.1 | 1D;2M.1 | |||
3Pal | PalMP | F | FAO | 1D;2M.1;3Pal
|
3c | PalMcP | F | FAO | 1D;2M.1;3Pal;3c
|
4M.2 | PalMP | F(N) | FAO | 1D;2M.1;3Pal;3c;4M.2
|
4M.5 | PalMP | F(N) | FAO | 1D;2M.1;3Pal;3c;4M.2;4M.5
|
4M1 | PalMP | F(N) | FAO | 1D;2M.1;3Pal;3c;4M.2;4M.5;4M1
|
4M2 | PalMP | F(N) | FAO | 1D;2M.1;3Pal;3c;4M.2;4M.5;4M1;4M2
|
5P | PalPMP | FN | FAO&CI | 1D;2M.1;3Pal;3c;4M.2;4M.5;4M1;4M2;5P
|
6G | PalPGMP | FN | FAO&CI | 1D;2M.1;3Pal;3c;4M.2;4M.5;4M1;4M2;5P;6G
|
7S10 | PalPGMSP | FNS | FAO&CI&II | 1D;2M.1;3Pal;3c;4M.2;4M.5;4M1;4M2;5P;6G;7S10
|
7S50 | PalPGMSP | FNS | FAO&CI&II | 1D;2M.1;3Pal;3c;4M.2;4M.5;4M1;4M2;5P;6G;7S10;7S50
|
8Gp | PalPGMSGpP | FNSGp | FAO&CI&II&GpDH | 1D;2M.1;3Pal;3c;4M.2;4M.5;4M1;4M2;5P;6G;7S10;7S50;8Gp
|
9U | PalPGMSGpE | FNSGp | FAO&CI&II&GpDH | 1D;2M.1;3Pal;3c;4M.2;4M.5;4M1;4M2;5P;6G;7S10;7S50;8Gp;9U
|
10Rot | SGpE | SGp | CII&GpDH | 1D;2M.1;3Pal;3c;4M.2;4M.5;4M1;4M2;5P;6G;7S10;7S50;8Gp;9U;10Rot
|
11Ama | ROX | 1D;2M.1;3Pal;3c;4M.2;4M.5;4M1;4M2;5P;6G;7S10;7S50;8Gp;9U;10Rot;11Ama
|
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- ยป Electron transfer pathway
- ยป Fatty acid oxidation pathway control state, F
- ยป NADH electron transfer-pathway state, N
- ยป Succinate pathway control state, S
- ยป NS-pathway control state, NS
- ยป Glycerophosphate pathway control state, Gp
- ยป Complex IV single step, CIV
- ยป Anaplerotic pathway control state
- Pathway control
- Main fuel substrates
- ยป Glutamate, G
- ยป Glycerophosphate, Gp
- ยป Malate, M
- ยป Octanoylcarnitine, Oct
- ยป Pyruvate, P
- ยป Succinate, S
- Main fuel substrates
- Glossary
Strengths and limitations
- SUIT-002 in combination with SUIT-001 provides a common reference for comparison of respiratory control in a large variety of species, tissues and cell types. Both SUIT protocols provide a mitochondrial mapping which allows:
- 1. to obtain reference values.
- 2. to evaluate mitochondrial physiological diversity, generating a mt-database on comparative mitochondrial physiology.
- 3. to screen specific defects.
- A succinate concentration of >10 mM may be required for saturating SE capacity.
- + SUIT-036 allows the depletion of endogenous substrates with ADP (1D).
- + The protocol provides information on F-pathway in OXPHOS state. The low concentration of malate used in this protocol, typically 0.1 mM, does not saturate the N-pathway; but saturates the F-pathway.
- + F-pathway (3Oct-2M.1) can be compared to FN-pathway (5P) in OXPHOS state.
- + Pathway control in OXPHOS (F, F(N), FN, FNS, FNSGp pathways) and in ET state (FNSGp and SGp) can be observed.
- + Harmonization with SUIT-001 allows to perform both SUIT protocols in parallel. The cross-linked respiratory states can be statistically used as repeated measurements.
- + Harmonization with many SUIT protocols (up to step 7S).
- + In SUIT-002, the full set of pathways converging into Q (FNSGp) is obtained in OXPHOS and ET states. Therefore, P/E (8Gp/9U) at high ET capacity can be calculated.
- + This protocol can be extended with the Complex IV module.
- - S-pathway in ET state is not obtained (it is obtained in SUIT-001).
- - Lengthy duration of the experiment.
- - We do not generally recommended the addition of already permeabilized cells, but we recommend to perform the permeabilization of the cell plasma membrane in the chambers (see SUIT-002 O2 ce-pce D007).
Compare SUIT protocols
- SUIT-002 O2 mt D005: Harmonized SUIT protocol for isolated mitochondria, tissue homogenate and permeabilized cells (already permeabilized).
Chemicals and syringes
Step | Chemical(s) and link(s) | Comments |
---|---|---|
1D | ADP (D) | |
2M.1 | Malate (M) | |
3Pal | Palmitoylcarnitine (Pal) | |
3c | Cytochrome c (c) | |
4M.2 | Malate (M) | |
4M.5 | Malate (M) | |
4M1 | Malate (M) | |
4M2 | Malate (M) | |
5P | Pyruvate (P) | |
6G | Glutamate (G) | |
7S10 | Succinate (S) | |
7S50 | Succinate (S) | |
8Gp | Glycerophosphate (Gp) | |
9U | Carbonyl cyanide m-chlorophenyl hydrazone, CCCP (U) | Can be substituted for other uncoupler |
10Rot | Rotenone (Rot) | |
11Ama | Antimycin A (Ama) |
- Suggested stock concentrations are shown in the specific DL-Protocol.